000 01302 a2200409 4500
005 20250514040917.0
264 0 _c20020805
008 200208s 0 0 eng d
022 _a0009-9147
040 _aNLM
_beng
_cNLM
100 1 _aNekulova, Mirka
245 0 0 _aPredicting response of ovarian cancer to paclitaxel treatment based on trend analysis of serum CA125.
_h[electronic resource]
260 _bClinical chemistry
_cAug 2002
300 _a1364-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents, Phytogenic
_xtherapeutic use
650 0 4 _aCA-125 Antigen
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aOvarian Neoplasms
_xdiagnosis
650 0 4 _aPaclitaxel
_xtherapeutic use
650 0 4 _aPrognosis
650 0 4 _aProspective Studies
650 0 4 _aReference Values
700 1 _aPecen, Ladislav
700 1 _aKalabova, Renata
700 1 _aSimickova, Marta
700 1 _aTopolcan, Ondrej
700 1 _aPikner, Richard
700 1 _aVondracek, Vladimir
700 1 _aValik, Dalibor
773 0 _tClinical chemistry
_gvol. 48
_gno. 8
_gp. 1364-7
999 _c12030144
_d12030144